European Lithium Ltd - Issue of Shares
RNS Number : 6315B
European Lithium Limited
09 October 2020

European Lithium Ltd

("European Lithium", "EUR" or "the Company")

Issue of Shares

European Lithium Limited (ASX:EUR, FRA:PF8, VSE:ELI, AQSE: EUR) (the Company) advises that a total of 1,106,383 fully paid shares (the Shares) have been issued. 


In respect to the shares issued, a total of 1,000,000 have been issued pursuant to a corporate advisor mandate (refer to announcement on 6 October 2020).  The balance of 106,383 shares have been issued to convert $5,000 of debt into equity. 


Application has been made for the Shares to be admitted to trading on AQSE ("Admission"). Admission is expected to occur at 8:00am on or around 15 October 2020. Following Admission, the Company's issued share capital will comprise 718,229,901 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.  The above figure of 718,229,901 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.


The full ASX announcement can be seen at:


- END -

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage



NEX Corporate Adviser

+44 207 220 1666

James Joyce

James Sinclair-Ford


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.